Reliance is key to effective access and oversight of medical products in case of public health emergenciesArticle Published on 2022-07-012023-07-10 Journal: Expert review of clinical pharmacology [Category] [DOI] 10.1080/17512433.2022.2088503 PMC 바로가기
SARS-CoV-2 Omicron Variants Reduce Antibody Neutralization and Acquire Usage of Mouse ACE2SARS-CoV-2 오미크론 변이체, 항체 중화 감소 및 마우스 ACE2 사용 획득Article Published on 2022-06-172022-09-11 Journal: Frontiers in Immunology [Category] [DOI] 10.3389/fimmu.2022.854952 PMC 바로가기 [Article Type] Article
Pharmacopoeia roles and responses: A systemic resilience approach to COVID-19 pandemicCorrespondence Published on 2022-05-012022-10-05 Journal: Saudi Pharmaceutical Journal : SPJ [Category] [DOI] 10.1016/j.jsps.2022.02.009 [Article Type] Correspondence
Biological Matrix Supply Chain Shortages: More Matrices Are Now Rare-the Case for Surrogate MatricesEditorial Published on 2022-03-142022-10-04 Journal: The AAPS Journal [Category] [DOI] 10.1208/s12248-022-00694-1 PMC 바로가기 [Article Type] Editorial
High-throughput immunoassays for SARS-CoV-2 – considerable differences in performance when comparing three methodsSARS-CoV-2에 대한 고처리량 면역분석 - 세 가지 방법을 비교할 때 성능의 상당한 차이Article Published on 2021-10-012022-09-11 Journal: Infectious diseases (London, England) [Category] [DOI] 10.1080/23744235.2021.1931434 PMC 바로가기 [Article Type] Article
Accelerated first-in-human clinical trial of EIDD-2801/MK-4482 (molnupiravir), a ribonucleoside analog with potent antiviral activity against SARS-CoV-2SARS-COV-2에 대한 강력한 항 바이러스 활성을 갖는 리보 뉴 클레오 사이드 유사체 인 EIDD-2801/MK-4482 (Molnupiravir)의 최초 인간 임상 시험의 가속화 된 인간 임상 시험.Randomized Controlled Trial Published on 2021-08-232022-08-13 Journal: Trials [Category] [DOI] 10.1186/s13063-021-05538-5 PMC 바로가기 [Article Type] Randomized Controlled Trial
Editorial: Post-Exposure Prophylactic Neutralizing Monoclonal Antibodies to SARS-CoV-2 for Individuals at High Risk for COVID-19사설: COVID-19 고위험군 개인을 위한 SARS-CoV-2에 대한 노출 후 예방 중화 단일클론 항체Editorial Published on 2021-08-162022-09-11 Journal: Medical science monitor : international medical jo [Category] [DOI] 10.12659/MSM.934393 PMC 바로가기 [Article Type] Editorial
Guiding axes for drug safety management of pharmacovigilance centres during the COVID-19 era코로나19 시대 약물감시센터 약물안전관리 안내축Article Published on 2021-08-012022-09-11 Journal: International journal of clinical pharmacy [Category] [DOI] 10.1007/s11096-021-01289-0 PMC 바로가기 [Article Type] Article
The COVID-19 vaccine development: A pandemic paradigmCOVID-19 백신 개발: 팬데믹 패러다임Review Published on 2021-08-012022-09-11 Journal: Virus research [Category] [DOI] 10.1016/j.virusres.2021.198454 PMC 바로가기 [Article Type] Review
Pharmacists’ involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policyCommentary Published on 2021-07-032022-10-30 Journal: International journal of clinical pharmacy [Category] [DOI] 10.1007/s11096-021-01301-7 PMC 바로가기 [Article Type] Commentary